Medspress(TM) Announces Webinar: The Art, Craft, and Science of Coffee

November 1, 2021 8:00 AM

CAPE TOWN, SA / ACCESSWIRE / November 1, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:Medspresso™ is pleased to announce its live coffee webinar is scheduled for Friday, 12 November 2021 at 15:00 SAST. The webinar will feature a panel of coffee experts with decades'...

Read more

Biophytis to Report Restated Financial Statements for Previous Periods and as of June 30, 2021

October 29, 2021 2:55 AM

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 29, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from...

Read more

EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes

October 28, 2021 10:00 AM

NASHVILLE, TN / ACCESSWIRE / October 28, 2021 / EV Biologics Corp, OTC Pink:YECO, today updated shareholders about a recent publication authored by its Chief Medical Officer, Dr. Jason Sanders.This review discusses some of the cellular and molecular pathology of COVID-19 and the relevant therapeutic mechanisms of small extracellular vesicles (EVs), such as exosomes, in Acute Lung Injury (ALI). The original manuscript was initially prepared by...

Read more

CB Scientific, Inc. Appoints Paul Danner as Chairman

October 28, 2021 6:00 AM

The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated successESCONDIDO, CA / ACCESSWIRE / October 28, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is a provider of remote ECG cardiac monitoring products and services; simple wearable solutions for detecting potentially life-threatening heart arrhythmias in patients with heart-related issues, both...

Read more

RepliCel Announces DermaPrecise Trademark for Dermal Injector Product Line

October 28, 2021 6:00 AM

Trademark registrations kickoff pre-commercial planningVANCOUVER, BC / ACCESSWIRE / October 28, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, announced today the DermaPrecise trademark for its dermal injector product portfolio."The DermaPrecise Injector is an electronic injection system which will bring new...

Read more

Invitation to Presentation of BioInvent’s Interim Report January–September 2021

October 28, 2021 2:30 AM

LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV)Lund, Sweden, October 28, 2021 - BioInvent International AB (Nasdaq Stockholm: BINV) invites to a presentation of the third quarter report 2021 and a telephone conference with CEO Martin Welschof. The presentation will be held in English.When: 2:00 p.m. CEST Thursday October 28, 2021.Listen to the presentation: https://tv.streamfabriken.com/bioinvent-q3-2021To...

Read more

BioInvent International AB Interim Report January - September 2021

October 28, 2021 2:30 AM

LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV)"The powerful combination of BioInvent's R&D and in-house manufacturing provides invaluable support to our clinical development and facilitates the execution of our current clinical portfolio. The integration of functions, on top of world leading science, makes it possible for us to develop novel treatments for patients suffering from serious diseases. The...

Read more

Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress

October 27, 2021 12:55 PM

SAN FRANCISCO, CA / ACCESSWIRE / October 27, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Pursuant to previous communications, Oncology Pharma, Inc. (the "Company") is making progress towards pursuing its primary goal of the Co-Development plan to bring new pharmaceutical drug formulations to market with a focused approach that aims to reduce overall costs and minimize time and duration to commercialization.The Company has developed the framework...

Read more

Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021

October 27, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / October 27, 2021 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2021 on Monday, November 1, 2021 after the market closes.In conjunction with the release, Apollo will...

Read more

Puradigm Announces Kansas State University Results on Inactivation of Foodborne Diseases

October 27, 2021 8:00 AM

Study determines Puradigm COOL Air and Surface Purification technology inactivates L. monocytogenes, E.coli, and A. niger by 99% in ice machinesSAN DIEGO, CA / ACCESSWIRE / October 27, 2021 / Puradigm a leading manufacturer of proactive air and surface purification technologies that have been proven to inactivate SARS-CoV-2, the virus responsible for COVID-19, and the Delta Variant, released the results of a study conducted by the Kansas State...

Read more

Itoco Provides Information About the Nopal Cactus' Ability To Act as a Key Component in Land Reclamation in Addition to Its Significant Carbon Reducing Properties

October 27, 2021 7:55 AM

TORONTO, ON / ACCESSWIRE / October 27, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to release information about the Nopal Cactus' ability to act as a key component to land reclamation in addition to its significant carbon reducing properties.Desertification or land degradation is occurring worldwide and directly affects millions of people, especially the poor. Nopal Cactus is already widely cultivated in arid regions worldwide as a standalone...

Read more

Black Bird Biotech Announces Hiring of National Sales General Manager for MiteXstreamTM; Sales Veteran to Lead U.S. Sales and Marketing Effort

October 26, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / October 26, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), exclusive manufacturer and distributor of plant-based MiteXstreamTM biopesticide, announced today that it has filled its National Sales General Manager opening with the hiring of experienced sales veteran, Rich Forbis. Mr. Forbis has been charged with implementing and overseeing the company's sales and marketing strategies for MiteXstreamTM, BBBT's...

Read more

Pieris Pharmaceuticals To Host Third Quarter 2021 Investor Call and Provide Corporate Update on November 2, 2021

October 26, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / October 26, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that it will host a third quarter 2021 investor call on Tuesday, November 2, 2021 at 8:00 AM EDT to discuss financial results and provide a corporate...

Read more

GenEp Raises $1.45 Million Seed Financing

October 26, 2021 7:00 AM

Financing will support development of first-in-class CNS-selective sodium channel modulatorsCHARLOTTESVILLE, VA / ACCESSWIRE / October 26, 2021 / GenEp, Inc., a biotechnology company developing therapies that address unmet needs in patients with epilepsy, announced today the closing of a $1.45 million seed financing. The financing was co-led by the UVA Licensing & Ventures Group Seed Fund, Angelini Lumira Biosciences Fund and 3B Future...

Read more

Applied UV Declares Monthly Preferred Stock Dividend

October 25, 2021 12:25 PM

MOUNT VERNON, NY / ACCESSWIRE / October 25, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the...

Read more

M2Bio Building A World Class Supply Chain Solution - Dr. Southey and Dr. Zarrebini Update on M2Bio Blockchain and Technology Group

October 25, 2021 8:00 AM

CAPE TOWN, SA / ACCESSWIRE / October 25, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:The M2Bio Blockchain Research & Technology Group is delighted to have completed Phase I development of the Company's Blockchain Supply Chain solution, with Phase II already underway....

Read more

BioInvent Appoints Immunotherapy Expert Alexander Eggermont to Scientific Advisory Board

October 25, 2021 7:45 AM

LUND, SWEDEN / ACCESSWIRE / October 25, 2021 / BioInvent International (STO:BINV)Holds extensive expertise in surgical oncology, immunotherapy, and drug developmentWill provide valuable input as BioInvent further expands clinical pipeline of cancer drugsBioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer...

Read more

Apollo Endosurgery Announces Positive MERIT-Trial Outcomes

October 22, 2021 4:05 PM

Trial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health ConditionsMERIT-Trial met its primary endpoints for safety and efficacy, with patients undergoing the Endoscopic Sleeve Gastroplasty (ESG) procedure achieving excess body weight loss of 49.2% at 12 months and a serious adverse event rate of 2%Patients undergoing ESG also had clinically significant reductions in...

Read more

enVVeno Medical Reports Successful Completion of First VenoValve Surgery for U.S. Pivotal Trial

October 22, 2021 9:00 AM

75 Patient Trial Underway to Evaluate Safety and Efficacy of the VenoValve as a Potential Treatment for Severe Deep Venous Chronic Venous Insufficiency (CVI)Severe CVI Impacts Approximately 2.4 million U.S. Patients with No Current Effective Treatment OptionsIRVINE, CA / ACCESSWIRE / October 22, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous...

Read more

ITOCO Welcomes Maria Teresa Tattersfield Yarza to Its Board of Directors and Carbon Credit Advisory Board

October 21, 2021 7:30 AM

TORONTO, ON / ACCESSWIRE / October 21, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to welcome Maria Teresa Tattersfield Yarza to its Board of Directors.Ms. Tattersfield will be presenting to and attending the meeting session COP 26, Glasgow, UK, from 25 Oct 2021 to 12 Nov 2021.COP26 is the annual United Nations Climate Change Conference. It is the largest Conference of its type in the world. The climate talks will be the largest international...

Read more